149 related articles for article (PubMed ID: 25976207)
1. M410, a combretastatin A4 analogue, disrupts microtubules and inhibits HIF-1α in human breast cancer cells.
Yang H; Xia Q; Zou Y; Wang K; Jiang W; Cai Y
Oncol Rep; 2015 Jul; 34(1):334-40. PubMed ID: 25976207
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410).
Cai YC; Zou Y; Ye YL; Sun HY; Su QG; Wang ZX; Zeng ZL; Xian LJ
Invest New Drugs; 2011 Apr; 29(2):300-11. PubMed ID: 20012336
[TBL] [Abstract][Full Text] [Related]
3. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
4. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor.
Sun L; Liu Y; Lin S; Shang J; Liu J; Li J; Yuan S; Zhang L
Acta Oncol; 2013 May; 52(4):842-51. PubMed ID: 23409769
[TBL] [Abstract][Full Text] [Related]
5. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
6. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
8. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
Kim DH; Hossain MA; Kim MY; Kim JA; Yoon JH; Suh HS; Kim GY; Choi YH; Chung HY; Kim ND
Int J Oncol; 2013 Dec; 43(6):1915-24. PubMed ID: 24100602
[TBL] [Abstract][Full Text] [Related]
9. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
10. [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells].
Jin XY; Ren CS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):495-9. PubMed ID: 18069627
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
Xia T; Cheng H; Zhu Y
Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
[TBL] [Abstract][Full Text] [Related]
12. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
[TBL] [Abstract][Full Text] [Related]
13. Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
Wei Z; Shan Y; Tao L; Liu Y; Zhu Z; Liu Z; Wu Y; Chen W; Wang A; Lu Y
Mol Carcinog; 2017 Oct; 56(10):2317-2331. PubMed ID: 28574600
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
Sun Y; Wang H; Liu M; Lin F; Hua J
Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
[TBL] [Abstract][Full Text] [Related]
15. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
16. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
17. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
Kim DH; Sung B; Kim JA; Kang YJ; Hwang SY; Hwang NL; Suh H; Choi YH; Im E; Chung HY; Kim ND
Int J Oncol; 2017 Aug; 51(2):715-723. PubMed ID: 28656256
[TBL] [Abstract][Full Text] [Related]
18. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
Shi L; He C; Li Z; Wang Z; Zhang Q
Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
[TBL] [Abstract][Full Text] [Related]
19. Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells.
Mir Hassani Z; Nabiuni M; Parivar K; Abdirad S; Karimzadeh L
Med Oncol; 2021 Jun; 38(7):77. PubMed ID: 34076777
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation.
Zhu X; Li Q; Li S; Chen B; Zou H
Int J Oncol; 2015 Jan; 46(1):215-22. PubMed ID: 25334080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]